معرفی
Rikje Ruiter is a Researcher in the Department of Epidemiology at Erasmus MC, a leading medical research institution in the Netherlands. Her work is deeply embedded in population-based studies, particularly leveraging data from the Rotterdam Study, with a focus on aging, chronic disease, medication use, and cancer risk.
Her research interests span epidemiology, cancer risk assessment, pharmacoepidemiology, and geriatric health outcomes. She investigates how long-term medication use, such as antihypertensives and psychotropics, influences disease risk and clinical outcomes in older adults. Her work also addresses multimorbidity, frailty, delirium, and the impact of environmental and genetic factors on health.
The trend in her recent publications shows a strong emphasis on validation studies, observational cohort analyses, and systematic reviews with applications in clinical prediction, public health, and personalized medicine. Her research frequently appears in high-impact journals in geriatrics, general practice, and epidemiology.
Scientific Contributions:
- Extensive work on cancer risk and registry-based epidemiology
- Key contributions to understanding medication effects in aging populations
- Leadership in studies on delirium, frailty, and multimorbidity in older patients
- Use of large-scale datasets like the Rotterdam Study for causal and predictive modeling
Rikje Ruiter has supervised doctoral research, as indicated by her involvement in a doctoral thesis, and has collaborated widely across national and international networks. While specific grant details are not listed, her research output suggests active participation in funded epidemiological and public health projects. She is not known to lead a standalone lab but is an integral part of collaborative research teams within the Department of Epidemiology.
